The impact of spironolactone on the lung injury induced by concomitant trastuzumab and thoracic radiotherapy

Yükleniyor...
Küçük Resim

Tarih

2019

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

IJRR-IRANIAN JOURNAL RADIATION RES

Erişim Hakkı

info:eu-repo/semantics/openAccess

Özet

Background: To evaluate impact of spironolactone (S) on pulmonary toxicity of concomitant use of thoracic radiotherapy (RT) and trastuzumab (T). Materials and Methods: Eighty rats were divided into eight groups: group (G) 1 was control group; G2, G3 and G4 were RT, S and T groups; G5, G6, G7 and G8 were RT+T, T+S, RT+S and RT+T+S groups respectively. Rats were sacrificed at 6 hour, 21 and 100 day after RT and lung samples were retrieved. Results: By 100th days of RT inflammation score, lung fibrosis score and TGF- expression were significantly different within study groups (p values were 0.002, 0.001 and 0.043 respectively). Inflammation score of G8 was significantly lower than inflammation scores of G2 and G5 (p values: G2-G8=0.004, and G5-G8=0.022). Inflammation score of G2 was significantly higher than G7 (p=0.028). There were significant differences regarding to fibrosis scores between G2-G8 (p=0.015), G2-G7 (p=0.017) and G5-G8 (p=0.011). TGF-beta expression was higher in both G2 and G5 when compared to G8 (p = 0.038). Conclusion: Our results suggested that S is an effective treatment option for improving radiation-induced pulmonary fibrosis. These findings should be clarified with further preclinical and clinical studies.

Açıklama

Anahtar Kelimeler

Aldosterone, pulmonary fibrosis, radiotherapy, spironolactone, Trastuzumab

Kaynak

INTERNATIONAL JOURNAL OF RADIATION RESEARCH

WoS Q Değeri

Q4

Scopus Q Değeri

Q3

Cilt

17

Sayı

1

Künye

Yavas, G., Yavas, C., Celik, E., Sen, E., Ata, O., Afsar, R. E. (2019). The Impact of Spironolactone on the Lung Injury Induced by Concomitant Trastuzumab and Thoracic Radiotherapy. International Journal of Radiation Research, 17(1), 87-95.